PAPER Beyer K, Lao JI, Gómez M, Riutort N, Latorre P, Mate JL, Ariza A

Alzheimer's disease and the cystatin C gene polymorphism: an association study.

Neurosci Lett. 2001 Nov 23;315(1-2):17-20. PubMed.

PAPER Brunelli T, Bagnoli S, Giusti B, Nacmias B, Pepe G, Sorbi S, Abbate R

The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease.

Neurosci Lett. 2001 Nov 23;315(1-2):103-5. PubMed.

PAPER Zhuang ZP, Kung MP, Hou C, Plössl K, Skovronsky D, Gur TL, Trojanowski JQ, Lee VM, Kung HF

IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain.

Nucl Med Biol. 2001 Nov;28(8):887-94. PubMed.

PAPER Maurage CA, Sergeant N, Ruchoux MM, Hauw JJ, Delacourte A

Paradoxical phosphorylation of the serine 199 on tau proteins from young individuals.

Neuroreport. 2001 Oct 29;12(15):3177-81. PubMed.

PAPER Poduslo JF, Curran GL

Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier.

Neuroreport. 2001 Oct 29;12(15):3197-200. PubMed.

PAPER Thomas T, Nadackal TG, Thomas K

Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation.

Neuroreport. 2001 Oct 29;12(15):3263-7. PubMed.

PAPER Laitinen KS, van Groen T, Tanila H, Venäläinen J, Männistö PT, Alafuzoff I

Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation.

Neuroreport. 2001 Oct 29;12(15):3309-12. PubMed.

PAPER Presente A, Andres A, Nye JS

Requirement of Notch in adulthood for neurological function and longevity.

Neuroreport. 2001 Oct 29;12(15):3321-5. PubMed.

PAPER Nicolaou M, Song YQ, Sato CA, Orlacchio A, Kawarai T, Medeiros H, Liang Y, Sorbi S, Richard E, Rogaev EI, Moliaka Y, Bruni AC, Jorge R, Percy M, Duara R, Farrer LA, St Georg-Hyslop P, Rogaeva EA

Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease.

Neurogenetics. 2001 Oct;3(4):203-6. PubMed.

PAPER Frederiks JA

Alzheimer's Disease and Related Disorders Annual 2001, Edited by S. Gauthier and J.L. Cummings, Martin Dunitz, London, 2001, 216 pp., ISBN 1-84184-022-X.

Clin Neurol Neurosurg. 2001 Dec;103(4):265. PubMed.

PAPER Tacnet-Delorme P, Chevallier S, Arlaud GJ

Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.

J Immunol. 2001 Dec 1;167(11):6374-81. PubMed.

PAPER Dutta K, Alexandrov A, Huang H, Pascal SM

pH-induced folding of an apoptotic coiled coil.

Protein Sci. 2001 Dec;10(12):2531-40. PubMed.

PAPER Werber EA, Rabey JM

The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia.

J Neural Transm. 2001 Nov;108(11):1319-25. PubMed.

PAPER Rainer M, Mucke HA, Krüger-Rainer C, Kraxberger E, Haushofer M, Jellinger KA

Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics.

J Neural Transm. 2001 Nov;108(11):1327-33. PubMed.

PAPER Mayeux R, Lee JH, Romas SN, Mayo D, Santana V, Williamson J, Ciappa A, Rondon HZ, Estevez P, Lantigua R, Medrano M, Torres M, Stern Y, Tycko B, Knowles JA

Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics.

Am J Hum Genet. 2002 Jan;70(1):237-43. PubMed.